seven cells semaglutide Modulates Extracellular Matrix Production of LX-2 via Exosomes and Improves Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Info Sheets LP | Seven

Other clinically relevant GI complications include cholelithiasis, which occurred about 50 % more often, and gastroesophageal reflux disease (GERD), which occurred roughly twice as often, in patients receiving GLP-1 therapies compared with placebo [33]

Excess weight is the strongest modifiable risk factor, fat deposits around the upper airway narrow the breathing passage, and abdominal fat reduces lung volume

[1] For Wegovy: Patients should press the auto-injector against the skin until they hear the second click and/or see the indicator window turn yellow, following the specific device instructions

These drugs are still being tested in large clinical trials

2 What's Next for Semaglutide